| Composition | Clopidogrel 75mg Aspirin 75mg |
|---|---|
| Dosage | TABLET |
| Packing Size | 20×10 |
| Packing | Alu-Alu |
At Avecia Healthcare, we believe that professionalism forms the foundation of trust. Our expert team is committed to providing healthcare solutions that meet global standards.
Every product we deliver is a result of thorough research, precision manufacturing, and rigorous quality checks—ensuring consistency in performance and reliability.
With a patient-first approach and a strong ethical foundation, we aim to make a lasting difference in lives by offering care that is both dependable and professionally crafted.
CLOPICON AP 75/75 Capsules
CLOPICON AP 75/75 is a combination medicine containing Clopidogrel 75 mg and Aspirin 75 mg, both recognized as effective antiplatelet agents. This dual therapy is prescribed for the prevention of blood clots, heart attack, ischemic stroke, and other thrombotic cardiovascular disorders. By inhibiting platelet aggregation, it ensures smooth blood circulation and reduces the chances of clot formation inside blood vessels.
Doctors commonly recommend CLOPICON AP 75/75 for patients with a history of acute coronary syndrome, ischemic heart disease, post-angioplasty, stent placement, or peripheral arterial disease. The combination of Clopidogrel and Aspirin provides a synergistic effect, making it more effective in reducing cardiovascular risks compared to single-drug therapy.
This capsule should be taken exactly as prescribed by the physician, usually once daily with or without food. Patients should not discontinue the medicine suddenly, as it may increase the risk of clotting and related complications.
Some individuals may experience side effects like gastritis, stomach irritation, minor bleeding, or bruising. Regular medical supervision and follow-up are important for long-term safety. When taken correctly, CLOPICON AP 75/75 plays a vital role in protecting heart health and preventing life-threatening clot-related conditions.
